Combination chemotherapy for the treatment of invasive infections by Scedosporium prolificans
- 1 June 2000
- journal article
- Published by Elsevier BV in Clinical Microbiology & Infection
- Vol. 6 (6), 336-337
- https://doi.org/10.1046/j.1469-0691.2000.00089.x
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- In Vitro Interaction of Terbinafine with Itraconazole against Clinical Isolates of Scedosporium prolificansAntimicrobial Agents and Chemotherapy, 2000
- Clinical, pathologic and epidemiologic features of infection with Scedosporium prolificans: four cases and reviewClinical Microbiology & Infection, 1999
- Antifungal Agents: Mode of Action, Mechanisms of Resistance, and Correlation of These Mechanisms with Bacterial ResistanceClinical Microbiology Reviews, 1999
- In Vitro Activity of Syn-2869, a Novel Triazole Agent, against Emerging and Less Common Mold PathogensAntimicrobial Agents and Chemotherapy, 1999
- Comparative in-vitro activity of voriconazole (UK-109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermumJournal of Antimicrobial Chemotherapy, 1999
- Successful Medical Therapy for Deeply Invasive Facial Infection Due toPythium insidiosumin a ChildClinical Infectious Diseases, 1998
- In vitro activities of terbinafine in combination with fluconazole and itraconazole against isolates of Candida albicans with reduced susceptibility to azolesAntimicrobial Agents and Chemotherapy, 1997
- In vitro antifungal activity of pneumocandin L-743,872 against a variety of clinically important moldsAntimicrobial Agents and Chemotherapy, 1997
- Activities of amphotericin B and antifungal azoles alone and in combination against Pseudallescheria boydiiAntimicrobial Agents and Chemotherapy, 1995